Peterlabs Holdings Bhd (XKLS:0171) ROCE % : 7.10% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Peterlabs Holdings Bhd ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Peterlabs Holdings Bhd's annualized ROCE % for the quarter that ended in Mar. 2024 was 7.10%.

Peterlabs Holdings Bhd ROCE % Historical Data

The historical data trend for Peterlabs Holdings Bhd's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peterlabs Holdings Bhd ROCE % Chart

Peterlabs Holdings Bhd Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

11.64

10.01

13.31

6.27

7.50

Peterlabs Holdings Bhd Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															7.80	5.66	9.03	7.52	7.10

Peterlabs Holdings Bhd ROCE % Calculation

Peterlabs Holdings Bhd's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	6.189	/	( ( (106.225 - 24.945)	+	(118.395 - 34.648) )	/ 2 )
	=	6.189	/	( (81.28	+	83.747)	/ 2 )
	=	6.189	/	82.5135
	=	7.50 %

Peterlabs Holdings Bhd's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	5.936	/	( ( (118.395 - 34.648)	+	(117.96 - 34.463) )	/ 2 )
	=	5.936	/	( ( 83.747	+	83.497 )	/ 2 )
	=	5.936	/	83.622
	=	7.10 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Peterlabs Holdings Bhd (XKLS:0171) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Peterlabs Holdings Bhd ROCE % Related Terms

Thank you for viewing the detailed overview of Peterlabs Holdings Bhd's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Peterlabs Holdings Bhd (XKLS:0171) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Peterlabs Holdings Bhd (XKLS:0171) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800

Website

https://www.peterlabs.com.my

Peterlabs Holdings Bhd is a Malaysia based company engaged in manufacturing, distribution, and trading of animal health and nutrition products. It also provides solutions like farm management, technical advisory services, raw material analysis and feed formulation. The operating segments of the group are Manufacturing which relates to manufacturing of animal health and nutrition products, and Trading which relates to trading and distribution of animal health and nutrition products. It offers products like animal feed additives, veterinary pharmaceuticals, injectable products, multi-nutrient and supplement, topical dressings, cleansing agents, and other related products. The company operates in Malaysia and internationally, and generates key revenue from the Trading segment.

Peterlabs Holdings Bhd (XKLS:0171) Headlines

No Headlines